Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000893220-09-000975
Filing Date
2009-04-30
Accepted
2009-04-30 13:39:51
Documents
3
Period of Report
2009-05-21
Effectiveness Date
2009-04-30

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY w73640def14a.htm DEF 14A 221344
2 GRAPHIC w73640w7364001.jpg GRAPHIC 244638
3 GRAPHIC w73640w7364002.jpg GRAPHIC 200150
  Complete submission text file 0000893220-09-000975.txt   836047
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50626 | Film No.: 09782492
SIC: 2834 Pharmaceutical Preparations